Sprott Inc’s bioAffinity Technologies BIAF Stock Holding History

Sprott Inc’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-333	Closed	-$2.87K	–	216
2025 Q2	$2.87K	Buy	+333	New	+$3.81K	﹤0.01%	207

Other funds holding BIAF

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

Sprott Inc's BIAF Position: Q3 2025 in Review

Sprott Inc sold out of bioAffinity Technologies (BIAF) in Q3 2025, closing a stake of 333 shares — an estimated $2.87K sold.

Sprott Inc first reported a position in BIAF in Q2 2025 and held it in 1 quarter. The position peaked at $2.87K in Q2 2025. 12 funds tracked by Wall St. Rank hold BIAF as of Q3 2025.

Sprott Inc reported no remaining bioAffinity Technologies position as of Q3 2025 after selling out during the quarter.
Sprott Inc sold 333 bioAffinity Technologies shares in Q3 2025, an estimated $2.87K.
Sprott Inc first reported a position in bioAffinity Technologies in Q2 2025 and held it in 1 quarter.
Sprott Inc's bioAffinity Technologies position peaked at $2.87K in Q2 2025.
12 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2025.

Based on Sprott Inc's 13F filing for Q3 2025, filed 12 Nov 2025.